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Summary. The circadian secretory profiles of serum prolactin, growth 
hormone and cortisol were measured in two women suffering from severe 
premenstrual tension syndrome and in two asymptomatic control subjects. 
Subjects and controls were screened and included after a rigorous selection 
process. Blood samples were obtained every 30 min over a period of 24 h 
in each woman both on day 9 (follicular phase) and day 26 (luteal phase) 
of the menstrual cycle. There was no relationship between the hormonal 
secretory profiles and the premenstrual tension syndrome. 
Many biological theories have been suggested to 
explain the premenstrual tension syndrome 
(PMTS) (Steiner & Carroll 1977). We have 
recently described the psychological changes that 
occur with severe PMTS (Haskett et al. 1980; 
Steiner et al. 1980), but the aetiological 
significance of the hormonal changes during the 
menstrual cycle is as yet unclear. The pattern of 
circulating sex steroid hormones and gonado- 
trophins in the course of the normal menstrual 
cycle have been well described in recent years 
(Punnonen el a/ .  1976; Kaulhausen e t a / .  1978). 
Studies which have attempted to demonstrate a 
link between PMTS and a relative imbalance of 
hormones, including not only oestrogens and pro- 
gesterone but also aldosterone, have produced 
conflicting results (Smith 1975; Backstrom & 
Mattsson 1975; Janowsky et al. 1973). 
Earlier reports of elevated prolactin (PRL) 
levels during the late luteal phase in women with 
PMTS (Halbreich et al. 1976; Horrobin et a/. 
1976) have not been confirmed by other 
investigators (Backstrom & Aakvaag 198 1; 
Steiner et al. 1983~1, b). 
In the present study we measured the circadian 
secretory profile of PRL at two points in the 
menstrual cycle in two women with severe PMTS, 
and compared them with two asymptomatic 
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control subjects. In addition, we examined the 
secretory profiles of growth hormone (GH) and 
cortisol to assess their relation to the severity of 
psychological distress and the possible contri- 
bution of a non-specific stress effect on these 
hormonal systems. 
Subjects and methods 
The project was approved by the Human Subject 
Review Committee of the University of Michigan 
and only subjects willing and able to give 
informed consent were included in the study. 
Two women with extremely severe PMTS were 
carefully selected from a large group of 
volunteers. They were 28 and 30 years of age, 
with no recent change in gynaecological function 
and no significant physical or psychiatric dis- 
order. They had taken no drugs for 1 month 
before the study and took none during the study. 
They had premenstrual dysphoric symptoms for 
at least six consecutive menstrual cycles. The 
‘Menstrual Distress Questionnaire-Today 
Form’ (MDQ-T) (Moos 1969) was used to 
demonstrate severity of symptoms and the 
on/off nature of the disturbance. Two women, 
matched for age, who were completely asympto- 
matic volunteered to be studied as controls. 
Ovulation was investigated in all four subjects 
using basal body temperature charts for 1 month 
before, and throughout, the month of the study. 
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The two subjects with PMTS and the two 
asymptomatic healthy controls were admitted to 
the clinical research centre for 24 h on days 9 and 
26 of their menstrual cycle (where day 1 was the 
onset of menses). The studies on day 9 (follicular 
phase) preceded those on day 26 (late luteal 
phase) in all subjects. Blood samples for PRL, 
G H  and cortisol were collected every 30 min for 
24 h from an indwelling catheter in the ante- 
cubital vein. The severity or the absence of 
symptoms in each subject was established by 
completing the MDQ-T form on the morning of 
each study day. The MDQ lists 47 symptoms 
each scored on a scale from 1 to 6 (minimum 
total score of 47 to a maximum total score of 
282) and the 'Today Form' (MDQ-T) is rated 
according to the symptoms present on the day of 
completing the scale. 
Serum PRL was measured by an established 
double antibody radio-immunoassay technique 
(Sinha et a/. 1973) with intra-assay variability of 
8.9%, inter-assay variability of 13.8% and 
sensitivity of 0.1 ng/tube. Human PRL (hPRL, 
AFP 1562-C) for iodination and standard was 
kindly provided by Dr Albert F. Parlow. 
The glucose oxidase-lactoperoxidase method 
described by Tower et a/ .  (1977) was used for 
iodination and the suitability of the '"I-PRL was 
verified by the talc-resin-TCA technique (Tower 
et a/. 1978). Anti-hPRL (AFP- 1) was supplied by 
the National Pituitary Agency. Values are 
reported as ng/ml of hPRL AFP 1562-C (see also 
Hays & Rubin 1979). 
GH was measured by a modified radio- 
immunoassay technique (Odell et a/. 1967). 
Human G H  standard preparation was HS-840; 
the iodination preparation was HS-1147-BC; and 
the G H  antibody had no number designation. 
These materials were received from the National 
Pituitary Agency through the courtesy of Dr 
Albert F. Parlow. All samples were tested in 
duplicate, and samples from each subject were 
tested in the same assay. Mean intra-assay 
variability was 5% and mean inter-assay varia- 
bility was 20%. The 50% intercept and (B/T), 
(percentage bound in the absence of unlabelled 
hormone) values were well within the tolerance 
ranges for our laboratory. 
Plasma cortisol was measured by the 
competitive protein-binding method of Murphy 
(1967) modified as described by Carroll et a/. 
(1 9 76). 
The data were analysed statistically using an 
analysis of variance with repeated measures. 
The cortisol, G H  and PRL circadian secretory 
profiles are presented in Figs 1-3. The mean daily 
serum levels for these three hormones and the 
corresponding MDQ-T scores are shown in Table 
1. 
The plasma cortisol levels showed a typical 
circadian secretory profile in the two subjects 
with PMTS and in the two controls on both 
occasions of sampling (Fig. 1). All eight cortisol 
profiles were well within normal limits as 
described by Krieger et al. (1971). The timing of 
the major circadian rise in cortisol secretion and 
the extent of spontaneous nocturnal inhibition of 
cortisol levels were similar in the follicular and 
late luteal phases. The one exception was the 
unexplained lack of nocturnal inhibition during 
the follicular phase in one of the controls (no. 3, 
D.F.D.). The mean daily plasma cortisol levels 
(Table 1) showed statistically significant 
differences between days 9 and 26 but the 
direction of change was not consistent in either 
the PMTS subjects or the controls and these 
differences probably have no physiological 
significance. 
The growth hormone secretory profiles were 
not remarkably different between days 9 and 26 
(Fig. 2). Nocturnal G H  elevations were seen in 
each woman, as were some spontaneous diurnal 
peaks. The mean daily plasma G H  levels are 
shown in Table 1. The mean differences between 
days 9 and 26 were weakly significant in one 
PMTS and in one control subject and although 
highly significant in the other control subject the 
change was in the opposite direction. 
The prolactin secretory profiles are shown in 
Fig. 3. A general elevation of PRL values 
throughout the circadian cycle was found in all 
the four women in the late luteal (premenstrual) 
phase. In one woman with PMTS (no. 2, A.B.L., 
Fig. 36) this increase was substantial and was 
recorded at a time when she had severe 
symptoms, with an extremely high MDQ-T total 
score of 194 (for comparative data see Moos 
1968; Gruba & Rohrbaugh 1975; Rouse 1978). 
A much smaller change was seen in the other 
woman with PMTS (no. 1, R.P.R., Fig. 3a) who 
was almost as symptomatic with a very high 
MDQ-T score of 17 1. 
It is notable that although both the asympto- 
matic control subjects denied ' any features oi 
PMTS, confirmed by their low MDQ-T score 
control subject no. 4 (S.E.S., Fig. 3 4  had 
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Fig. 1. Circadian cortisol profiles in two women with severe premenstrual tension syndrome (a & b) and two 
asymptomatic control subjects (c B d) during the follicular ( 0 2 )  and luteal (0-  - ~ - -0) phases of the 
menstrual cycle. 
marked elevation of PRL during the late luteal significant difference in the same direction was 
(premenstrual) phase. seen in one of the asymptomatic control subjects. 
Well-defined early morning maxima of PRL 
levels were present in only some women and were Discussion 
inconsistent between phases. 
The mean daily PRL levels (Table 1) were The cortisol and GH results in our study do not 
significantly higher in the two women with PMTS indicate a major neuro-endocrine stress or arousal 
during the late luteal phase but the most response associated with PMTS. The elevated 
Table 1. Mean 24-h plasma levels of prolactin (PRL), growth hormone (GH) and cortisol in two women with severe 
premenstrual tension syndrome (PMTS) and two asymptomatic control subjects 
Day 24-h plasma levels 
cycle PRL (ng/ml) GH (ng/ml) Cortisol (pg/dl) score 
MDQ-T Subject of 
PMTS 
no. 1 (R.P.R.) 9 
26 
no. 2 (A.B.L.) 9 
26 
Control 
no. 3 (D.F.D.) 9 



































Results are mean t S E M .  
Significance of differences: *P<0.05; **P<O.OI ; ***P<O.OOI ; NS, not significant. 
MDQ-T, 'Menstrual Distress Questionnaire-Today'. 
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Fig. 2. Circadian growth hormone profiles in two women with severe premenstrual tension syndrome (a  & b) and 
two asymptomatic control subjects (c & d) during the follicular (M) and luteal (0-  - - - -0) phases of the 
menstrual cycle. 
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Fig. 3. Circadian prolactin profiles in two women with severe premenstrual syndrome ( a  & b) and two asymptomatic 
control subjects (c & d) during the follicular (0-0) and luteal(0- - - - - -0) phases of the menstrual cycle. 
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PRL levels are also unlikely t o  be the result of 
nonspecific stress of PMTS. We found no support  
for the hypothesis that  P M T S  is associated with 
hyperprolactinaemia (see also O’Brien & 
Symonds 1982). Markedly elevated PRL levels 
were seen in the absence of  PMTS. 
I t  is clear f rom our d a t a  tha t  measurement of 
circadian profiles is superior to plasma level 
estimation in single samples. T h e  pulsatile 
secretion pattern of these hormones clearly 
demonstrates the difficulties of interpreting values 
obtained from single samples. We have also 
demonstrated tha t  the  comparison of mean daily 
hormone levels with behavioural observations 
that  are  scored once a d a y  does not  appear  t o  be  
meaningful. The relation between changes in 
hormonal secretion and  PMTS remains unclear. 
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